ACE and Stroke: Although no major studies have been performed on stroke patients that chose MAU as a target for therapy, several studies on hypertensive, diabetic, and patients with increased cardiovascular risk showed that MAU levels could be decreased by administering angiotensin receptor blockers or angiotensin-converting enzyme inhibitor [133,134].